EUCTR2019-003728-19-BE进行中（未招募）1 期
Intestinal disposition of mesalazine in healthy volunteers
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- KU Leuven
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Healthy volunteers
- •aged between 18 and 35
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 8
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Allergic to PPI or mesalazine
- •Acute/chronic gastro-intestinal disease
- •diabetic, cardiovascular disease, pulmonitis, or renal disease
- •(possible) pregnancy and when breastfeeding
- •medicine (contraception excluded)
- •HIV, HBV or HVC contamination
- •lactose intolerant
- •Allergic to soy or peanuts
研究者
相似试验
进行中（未招募）
1 期
Gastrointestinal behaviour of mesalazine in healthy volunteersHealthy volunteersEUCTR2019-001009-26-BEKU Leuven - Drug Delivery and Disposition10
已完成
不适用
Comparison of rectal with oral mesalazine in the treatment of Ulcerative Proctitis (CORRECT Study)lcerative colitisJPRN-UMIN000010340Saitama Medical Center, Saitama Medical University60
已完成
1 期
A study of a new gastro-resistant prolonged-release mesalazine tablet formulatioChronic inflammation of the intestinal epitheliumDigestive SystemISRCTN95265400Mogon Pharmaceuticals Sagl16
已完成
不适用
rinary excretion levels of MMX-mesalazine in healthy volunteersrinary excretion MMX-mesalazine, pharmacokinetics. Now studied in healthy volunteers. To be used in inflammatory bowel disease (IBD) patients in the future.Digestive SystemISRCTN15765858Radboud University Nijmegen Medical Centre25
尚未招募
不适用
The involvement of mesalazine concentration in colonic mucosa of patients with ulcerative colitis under treatment with oral mesalazinelcerative ColitisJPRN-UMIN000011455Department of Gastroenterology and Hepatology, Kyoto University Hospital50